Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. DKSH Holding AG
  6. News
  7. Summary
    DKSH   CH0126673539

DKSH HOLDING AG

(DKSH)
  Report
Delayed Swiss Exchange  -  11:30 2022-09-29 am EDT
71.15 CHF   +1.28%
05:30aDKSH's Healthcare Unit Partners With Leo Pharma to Deliver Therapeutic Products in Asia
MT
01:00aLEO Pharma and DKSH Partners to Deliver Products and Solutions to People in Asia with Skin Conditions and Thrombosis
CI
09/22Global markets live: Veolia, Meta, Amazon, Salesforce, Target...
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DKSH Reports Good Half-Year 2022 Results

07/15/2022 | 12:57am EDT

DKSH Management Ltd. / Key word(s): Half Year Results
DKSH Reports Good Half-Year 2022 Results

15-Jul-2022 / 06:55 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

  • EBIT increased by 16.6% to CHF 153.3 million (19.9% at CER¹) driven by all four Business Units
  • EBIT margin expanded by 30 basis points to 2.7%
  • Net sales grew by 2.0% to CHF 5,596.2 million (3.7% at CER¹)
  • RONOC increased by 170 basis points to 20.4%
  • Disciplined strategy and M&A execution (six acquisitions signed)
  • Confirmed outlook for 2022

 

Key Figures Group (CHF million)

H1 2022

H1 2021

△ in % CHF

△ in % CER1

Net sales

5,596.2

5,487.9

2.0

3.7

Operating profit (EBIT)

153.3

131.5

16.6

19.9

Profit after tax

105.7

86.7

21.9

24.5

Free Cash Flow

72.1

107.2

(32.7)

-

RONOC (in%)

20.4%

18.7%

-

-

1 Constant exchange rates (CER): 2022 figures converted at 2021 exchange rates

 

Zurich, Switzerland, July 15, 2022 – DKSH reported good half-year 2022 results. EBIT increased by 16.6% to CHF 153.3 million and net sales grew 2.0% reaching CHF 5,596.2 million. All four Business Units recorded higher profits. In addition, DKSH signed six acquisitions, increased its digital business double digits, and made good progress on its Sustainability (ESG) roadmap.

DKSH CEO Stefan P. Butz said: “I am pleased with the results achieved so far in the challenging environment of 2022. After a successful 2021, we continue moving forward with solid growth and profitability improvements. We accelerated M&A, further digitalized our business, and made good progress in our ESG agenda. We will keep working hard to continue delivering value to all our stakeholders and on our purpose.”

DKSH Group

In the first half of 2022, Group net sales grew by 2.0% and reached CHF 5,596.2 million. Organic growth contributed the most at 3.0% while acquisitions added 0.7%, resulting in a growth in constant exchange rates of 3.7%. The strengthening of the Swiss franc had a negative impact of 1.7% in the period.

EBIT reached CHF 153.3 million in the first half of 2022, 16.6% higher than the previous year, while the EBIT margin expanded by more than 30 basis points from 2.4% to 2.7%. Profit after tax was CHF 105.7 million and Free Cash Flow reached CHF 72.1 million. Volatile supply chains and strong growth in Business Unit Performance Materials resulted in temporary higher inventory levels, offset by a reduction in receivables due to faster cash collection.

Business Unit Healthcare

Business Unit Healthcare delivered organic growth and solid EBIT margin improvement, driven by a leaner structure, acquisitions and a higher share of value-added products. The business continued to catch-up from the pandemic and experienced high demand for COVID related products. The Business Unit also announced the acquisition of Acutest Systems in Malaysia.

 

Healthcare (in CHF million)

H1 2022

H1 2021

△ in % CHF

△ in % CER1

Net sales

2,803.4

2,753.0

1.8

3.1

Operating profit (EBIT)

74.0

61.8

19.7

22.3


Business Unit Consumer Goods

Business Unit Consumer Goods delivered double-digits EBIT growth as it continues its transformation journey. The business continued benefitting from a leaner and more agile structure, ongoing product portfolio rationalization, and consistent strategy execution. EBIT margin increased 20 basis points from 1.9% to 2.1%. Net sales remained broadly unchanged compared to last year. Reasonable product price increases and lower volumes combined with lockdowns as well as supply chain disruptions in some Asian markets balanced each other out.

 

Consumer Goods (in CHF million)

H1 2022

H1 2021

△ in % CHF

△ in % CER1

Net sales

1,867.1

1,914.3

(2.5)

(0.9)

Operating profit (EBIT)

39.9

35.7

11.8

13.8


Business Unit Performance Materials

Business Unit Performance Materials recorded double-digit net sales growth, benefitting from positive industry demand in Europe and Asia Pacific. EBIT increased by 7.5%¹, and excluding Japan, EBIT was up by 16.5%1 compared to last year. DKSH continued consolidating the global specialty chemicals and ingredients market by signing four acquisitions in the first half of 2022.

 

Performance Materials (in CHF million)

H1 2022

H1 2021

△ in % CHF

△ in % CER1

Net sales

719.4

633.2

13.6

17.9

Operating profit (EBIT)

63.2

61.1

3.4

7.5


Business Unit Technology

Business Unit Technology achieved an encouraging performance in the first six months of the year and DKSH is confident that it will continue to rebound from the pandemic and deliver a strong second half of 2022. Following movement restrictions in 2021, the service business started to gradually return to normal, which boosted results. The Business Unit also announced the acquisition of DNIV Group, a major player in the dynamic semiconductor and electronics distribution segment in Asia.

 

Technology (in CHF million)

H1 2022

H1 2021

△ in % CHF

△ in % CER1

Net sales

206.3

187.4

10.1

11.7

Operating profit (EBIT)

5.4

2.2

145.5

136.4


Outlook

DKSH expects EBIT growth in 2022. The outlook assumes GDP growth in Asia Pacific, stable exchange rates, and barring unforeseen events (excluding special items). DKSH remains confident about Asia's long-term potential and is well positioned to benefit from favorable market, industry, and consolidation trends.

Further Information

The investor and media conference will take place today at 10:00 a.m. CET. The Half-Year Report 2022 and recording of the investor webcast will be available on the DKSH website.

 

Appendix: Reconciliation Table Net Sales

(in CHF million)

H1 2022

H1 2021

% CHF

% organic*

% M&A*

% FX*

DKSH Group

5,596.2

5,487.9

2.0

3.0

0.7

(1.7)

Healthcare

2,803.4

2,753.0

1.8

2.7

0.4

(1.3)

Consumer Goods

1,867.1

1,194.3

(2.5)

(1.0)

0.1

(1.6)

Performance Materials

719.4

633.2

13.6

15.7

2.2

(4.3)

Technology

206.3

187.4

10.1

6.6

5.1

(1.6)

* Organic: Difference 2022 figures to 2021 figures excluding M&A and FX

M&A: Hahn Healthcare and Medworkz (Healthcare), STP (Consumer Goods), Sacoa, HTBA and RBC (Performance Materials) as well as Bosung (Technology)

  FX: Impact from currency translation on net sales

About DKSH 
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. www.dksh.com

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Rafael Duarte
Director, Group Investor Relations
Phone +41 44 386 7318
rafael.duarte@dksh.com

Demet Biçer
Manager, Group Media Relations
Phone +41 44 386 7217
demet.bicer@dksh.com



End of ad hoc announcement
Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 1398493

 
End of Announcement EQS News Service

1398493  15-Jul-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1398493&application_name=news&site_id=zonebourse_sftp

© EQS 2022
All news about DKSH HOLDING AG
05:30aDKSH's Healthcare Unit Partners With Leo Pharma to Deliver Therapeutic Products in Asia
MT
01:00aLEO Pharma and DKSH Partners to Deliver Products and Solutions to People in Asia with S..
CI
09/22Global markets live: Veolia, Meta, Amazon, Salesforce, Target...
MS
09/22Switzerland's DKSH to Buy North American Chemicals Distributor Terra Firma in $360 Mill..
MT
09/22DKSH Performance Materials Strengthens its North American Presence With the Acquisition..
EQ
09/22DKSH Holding AG agreed to acquire Terra Firma.
CI
09/18Dksh : Opens Five new Innovation Centers in China for the Specialty Chemicals and Personal..
PU
09/14Dksh : Joins Global Efforts to Keep Malaysia's Beaches Clean
PU
09/07Strange times
MS
09/07Switzerland's DKSH Wins Exclusive Licensing Deal to Market Five Potential Biosimilars i..
MT
More news
Analyst Recommendations on DKSH HOLDING AG
More recommendations
Financials
Sales 2022 11 503 M 11 739 M 11 739 M
Net income 2022 219 M 223 M 223 M
Net cash 2022 181 M 185 M 185 M
P/E ratio 2022 21,4x
Yield 2022 2,99%
Capitalization 4 622 M 4 717 M 4 717 M
EV / Sales 2022 0,39x
EV / Sales 2023 0,36x
Nbr of Employees 31 160
Free-Float 49,3%
Chart DKSH HOLDING AG
Duration : Period :
DKSH Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DKSH HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 71,15 CHF
Average target price 86,25 CHF
Spread / Average Target 21,2%
EPS Revisions
Managers and Directors
Stefan P. Butz Chief Executive Officer
Ido Wallach Chief Financial Officer
Marco Gadola Chairman
Sam Oh Chief Information Officer
Laurent Sigismondi Secretary, General Counsel & Head-Governance
Sector and Competitors
1st jan.Capi. (M$)
DKSH HOLDING AG-6.71%4 657
CINTAS CORPORATION-10.97%40 060
TELEPERFORMANCE SE-34.44%14 640
EDENRED SE15.16%11 228
BUREAU VERITAS SA-21.52%9 986
LG CORP.-7.91%8 181